1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2016 Emerging Opportunities in the Japan Infectious Disease Molecular Diagnostics Market: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review (DataPack)

This DataPack contains tables from VPGMarketResearch.com new report, "2016 Emerging Opportunities in the Japan Infectious Disease Molecular Diagnostics Market: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review.”

For pricing information on DataPack sections or individual tables, please contact Customer Service.

Table Of Contents

2016 Emerging Opportunities in the Japan Infectious Disease Molecular Diagnostics Market: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review (DataPack)
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests

Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests

Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests

Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Spain
Molecular Diagnostics Test Volume And Sales
by Major Application 2014-2019
Spain
Laboratories Performing DNA Sequencing
by Market Segment 2014
Spain
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014

Spain
Molecular Diagnostics Test Volume
by Major Application 2014-2019
Spain
Major Infectious Disease Test Volume by Assay 2014-2019
Spain
Major Infectious Disease Test Volume by Method 2014
Spain
Molecular Diagnostics Market
by Major Application 2014-2019
Spain
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
Spain
Major Infectious Disease Diagnostics Market by Assay 2014-2019
Spain
AIDS Testing Market
Estimated Sales by Major Supplier 2014
Spain
Chlamydia Testing Market
Estimated Sales by Major Supplier 2014
Spain
CMV Testing Market
Estimated Sales by Major Supplier 2014
Spain
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
Spain
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014

Spain
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
Spain
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
Spain
Herpes Testing Market
Estimated Sales by Major Supplier 2014
Spain
Influenza Testing Market
Estimated Sales by Major Supplier 2014
Spain
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
Spain
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

  • $ 9600
  • Industry report
  • January 2017
  • by Venture Planning Group

About this Report This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are ...

Respiratory Diagnostics Market by Product & Service, Test Type, Disease, End User - Global Forecast to 2021

Respiratory Diagnostics Market by Product & Service, Test Type, Disease, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global respiratory diagnostics market is projected to reach USD 7.45 billion by 2021 from USD 5.24 billion in 2016, at a CAGR of 7.3% from 2016 to 2021. Increasing prevalence of respiratory diseases, ...

Transplant Diagnostics Market by Technology, Products & Services, Application, End User - Global forecast 2021

Transplant Diagnostics Market by Technology, Products & Services, Application, End User - Global forecast 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global transplant diagnostics market is estimated to grow at a CAGR of 7.0% during the forecast period and is expected to be valued at USD 4.36 billion by 2021. Although the mature markets (North America ...


Download Unlimited Documents from Trusted Public Sources

Global Infectious Disease Statistics - Forecast

  • May 2016
    24 pages
  • Infectious Dise...  

    Molecular Diagn...  

  • World  

    United States  

    North America  

View report >

Diagnostics Industry in Canada

  • January 2017
    11 pages
  • Canada  

View report >

The future of the Clinical Trial Industry in the US

  • January 2017
    2 pages
  • Clinical Trial  

    Genome Sequenci...  

    Biopsy  

  • United States  

View report >

Related Market Segments :

Infectious Disease

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.